BetterLife Pharma Inc. announced a non-brokered private placement of 1,750,000 units at a price of CAD 0.10 per unit for aggregate gross proceeds of CAD 175,000 on June 13, 2024. Each Unit is comprised of one common share and one full warrant. Each warrant entitles the holder thereof to acquire one common share at an exercise price of CAD 0.13 at any time up to 24 months from the closing of the Offering.

The Units sold pursuant to the Offering will be subject to a four month hold period pursuant to applicable Canadian securities laws.